Citigroup Inc. vs Johnson & Johnson — how do they compare? Citigroup Inc. trades at $135.15 (market cap $227.30B), while Johnson & Johnson trades at $247.75 (market cap $611.07B). The key difference: Johnson & Johnson is far larger — about 2.7× Citigroup Inc.'s market cap, and Johnson & Johnson pays the higher dividend (2.11%). Which is the better fit depends on your goals.
| C | JNJ | |
|---|---|---|
Market Cap | $227.30B | $611.07B |
Sector | Financials | Health |
52-Week High | $145.67 | $267.24 |
52-Week Low | $90.02 | $162.98 |
Dividend Yield | 1.8% | 2.11% |
Volume | — | 6,156,228 |
Enterprise Value | — | $644.01B |
Trailing returns across standard periods
Latest headlines on both assets
Citigroup Inc. is a diversified financial services holding company that provides a broad range of financial services to consumer and corporate customers. The Company services include investment banking, retail brokerage, corporate banking, and cash management products and services. Citigroup serves customers globally.
Read more on C →Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →